Tiff Caza
@glombandit.bsky.social
I am a kidney pathologist and researcher seeking personal and professional growth. I work at Arkana Labs, but posts are my own opinions.
Hi 👋. I'm Tiff Caza, a kidney pathologist and #NephJC fan! Looking forward to learning about IgA. No COI. Hoping to see some of you all at Kidney Week next week 🙂
October 29, 2025 at 1:10 AM
Hi 👋. I'm Tiff Caza, a kidney pathologist and #NephJC fan! Looking forward to learning about IgA. No COI. Hoping to see some of you all at Kidney Week next week 🙂
Hi! I'm Tiff Caza, a kidney pathologist and huge #NephJC fan. Loved this book and rooting for Henry throughout 🙂. No true COI, but was exposed to TB from an autopsy and am privileged to be able to have no problem affording prophylaxis.
August 20, 2025 at 1:05 AM
Hi! I'm Tiff Caza, a kidney pathologist and huge #NephJC fan. Loved this book and rooting for Henry throughout 🙂. No true COI, but was exposed to TB from an autopsy and am privileged to be able to have no problem affording prophylaxis.
Lupus nephritis - this one is going out to Rush Nephrology 🎨@nephrowhitt.bsky.social
July 15, 2025 at 10:43 PM
Lupus nephritis - this one is going out to Rush Nephrology 🎨@nephrowhitt.bsky.social
Some conclusions from a great talk on monoclonal gammopathies of renal significance from Dr. Nasr at @glomcon.org today:
May 25, 2025 at 4:14 PM
Some conclusions from a great talk on monoclonal gammopathies of renal significance from Dr. Nasr at @glomcon.org today:
New MGRS entity in the IKMG classification - intracapillary monoclonal IgM glomerulopathy
From Dr. Nasr at @glomcon.org
From Dr. Nasr at @glomcon.org
May 25, 2025 at 4:13 PM
New MGRS entity in the IKMG classification - intracapillary monoclonal IgM glomerulopathy
From Dr. Nasr at @glomcon.org
From Dr. Nasr at @glomcon.org
Most monotypic fibrillary glomerulopathy is not a MGRS lesion and is being removed from the MGRS classification. An exception though is heavy chain fibrillary GN, which can be driven by a monoclonal paraprotein.
By Dr. Nasr at @glomcon.org
By Dr. Nasr at @glomcon.org
May 25, 2025 at 4:12 PM
Most monotypic fibrillary glomerulopathy is not a MGRS lesion and is being removed from the MGRS classification. An exception though is heavy chain fibrillary GN, which can be driven by a monoclonal paraprotein.
By Dr. Nasr at @glomcon.org
By Dr. Nasr at @glomcon.org
The majority of crystalglobulinemic nephropathy cases have extrarenal manifestations. The clinical presentation is often robust with severe AKI.
By Dr. Nasr at @glomcon.org
By Dr. Nasr at @glomcon.org
May 25, 2025 at 4:11 PM
The majority of crystalglobulinemic nephropathy cases have extrarenal manifestations. The clinical presentation is often robust with severe AKI.
By Dr. Nasr at @glomcon.org
By Dr. Nasr at @glomcon.org
Ancillary techniques used in the diagnosis of MGRS lesions. By Dr. Nasr at @glomcon.org
May 25, 2025 at 4:09 PM
Ancillary techniques used in the diagnosis of MGRS lesions. By Dr. Nasr at @glomcon.org
Atypical anti-GBM disease can either be monotypic or polytypic.
By Dr. Nasr at @glomcon.org
By Dr. Nasr at @glomcon.org
May 25, 2025 at 4:08 PM
Atypical anti-GBM disease can either be monotypic or polytypic.
By Dr. Nasr at @glomcon.org
By Dr. Nasr at @glomcon.org
The majority (but not all) cryoglobulinemic GNs have organized deposits. The morphology of the ultrastructural deposits can sometimes have overlap with the appearance of deposits of other entities (such as fibrillary and immunotactoid GN).
May 25, 2025 at 4:07 PM
The majority (but not all) cryoglobulinemic GNs have organized deposits. The morphology of the ultrastructural deposits can sometimes have overlap with the appearance of deposits of other entities (such as fibrillary and immunotactoid GN).
Pathophysiology of various MGRS lesions:
By Dr. Nasr at @glomcon.org
By Dr. Nasr at @glomcon.org
May 25, 2025 at 4:02 PM
Pathophysiology of various MGRS lesions:
By Dr. Nasr at @glomcon.org
By Dr. Nasr at @glomcon.org
More than one MGRS lesion is not uncommon on biopsy.
By Dr. Nasr at @glomcon.org
By Dr. Nasr at @glomcon.org
May 25, 2025 at 3:59 PM
More than one MGRS lesion is not uncommon on biopsy.
By Dr. Nasr at @glomcon.org
By Dr. Nasr at @glomcon.org
There is a spectrum of crystalline nephropathies that represent monoclonal gammopathies of renal significance. Paraffin immunofluorescence for kappa and lambda light chains are often required in diagnosis for detection.
By Dr. Nasr at @glomcon.org
By Dr. Nasr at @glomcon.org
May 25, 2025 at 3:58 PM
There is a spectrum of crystalline nephropathies that represent monoclonal gammopathies of renal significance. Paraffin immunofluorescence for kappa and lambda light chains are often required in diagnosis for detection.
By Dr. Nasr at @glomcon.org
By Dr. Nasr at @glomcon.org
Some take home messages from an inspiring talk by @nephrorock.bsky.social at @kidneycon.bsky.social !
May 3, 2025 at 4:11 AM
Some take home messages from an inspiring talk by @nephrorock.bsky.social at @kidneycon.bsky.social !
They gave us some fun buttons at work today 😊
April 30, 2025 at 1:35 AM
They gave us some fun buttons at work today 😊
Hi everyone 👋. I'm Tiff Caza, a kidney pathologist and #NephJC fan-girl. Not a fan of microvascular inflammation (just as no one should be). No COI.
And Happy ApoL1 awareness day friends!
And Happy ApoL1 awareness day friends!
April 30, 2025 at 1:05 AM
Hi everyone 👋. I'm Tiff Caza, a kidney pathologist and #NephJC fan-girl. Not a fan of microvascular inflammation (just as no one should be). No COI.
And Happy ApoL1 awareness day friends!
And Happy ApoL1 awareness day friends!
SGLT2 inhibitors can have a complement inhibition effect.
By @changucanspare.bsky.social at @glomcon.org
By @changucanspare.bsky.social at @glomcon.org
April 27, 2025 at 3:35 PM
SGLT2 inhibitors can have a complement inhibition effect.
By @changucanspare.bsky.social at @glomcon.org
By @changucanspare.bsky.social at @glomcon.org
Scleroderma renal crisis only impacts ~10% of those with scleroderma and may be complement mediated.
By @changucanspare.bsky.social at @glomcon.org
By @changucanspare.bsky.social at @glomcon.org
April 27, 2025 at 3:33 PM
Scleroderma renal crisis only impacts ~10% of those with scleroderma and may be complement mediated.
By @changucanspare.bsky.social at @glomcon.org
By @changucanspare.bsky.social at @glomcon.org
In clinical laboratory studies for TMA, you may have relative (rather than absolute thrombocytopenia) and often do not see schistocytes on peripheral smears (or require serial measurements).
By @changucanspare.bsky.social at @glomcon.org
By @changucanspare.bsky.social at @glomcon.org
April 27, 2025 at 3:31 PM
In clinical laboratory studies for TMA, you may have relative (rather than absolute thrombocytopenia) and often do not see schistocytes on peripheral smears (or require serial measurements).
By @changucanspare.bsky.social at @glomcon.org
By @changucanspare.bsky.social at @glomcon.org
April 27, 2025 at 3:30 PM
Hi friends 👋. I'm Tiff Caza, a kidney pathologist and big #NephJC fan! Late to the party but looking forward to learning tonight. Have my furry friend joining me. No COIs.
April 16, 2025 at 1:10 AM
Hi friends 👋. I'm Tiff Caza, a kidney pathologist and big #NephJC fan! Late to the party but looking forward to learning tonight. Have my furry friend joining me. No COIs.
Beautiful autobiography of a patient's journey with PKD. 💚
April 7, 2025 at 1:30 AM
Beautiful autobiography of a patient's journey with PKD. 💚
Hi! I'm Tiff Caza, a kidney pathologist and big #NephJC fan. I love to hate lupus, but otherwise have no COI. Looking forward to discussing this trial!
March 12, 2025 at 1:07 AM
Hi! I'm Tiff Caza, a kidney pathologist and big #NephJC fan. I love to hate lupus, but otherwise have no COI. Looking forward to discussing this trial!
